Meet the First Baby Ever Treated with Cannabis Oil at The Hospital

"For The First Time Ever, Cannabis Oil Will Be Used In A Hospital, 
 To Save A 2-Month-Old Baby Girl..."

In December, Nicole and Ernie Nunez brought their beautiful baby girl, Amylea, into the world. However, when they brought her home, things quickly took a turn for the worst.

"Why We Have Cannabinoid Receptors and what they mean for overall health"?

"Cannabis has been a part of human life for over 10,000 years. Here’s why we have cannabinoid receptors and what they mean for overall health".

Have you ever wondered why cannabis has such strong medicinal and psychoactive effects? The herb interacts with the body in ways that no other plant can. The plant contains chemical compounds that are unique to cannabis alone, making it an anomaly in the great wide world of flora. These compounds are called cannabinoids and they are able to engage with special landing locations on human cells. But, why do we have these cannabinoid receptors, anyway?

U.K Government announces that medicinal cannabis is legal

       Patients can be prescribed medicinal cannabis by specialist doctors 

       from 1 November 2018.

For the first time in the UK, expert doctors have been given the option to legally issue prescriptions for cannabis-based medicines when they agree that their patients could benefit from this treatment.

More than $2.2 billion invested in cannabis industry in October

This weekly series from Marijuana Business Daily and Viridian Capital Advisors provides the latest data on cannabis investment activity and M&A, along with key takeaways, analysis and trends based on recent market moves.

The data below, provided by Viridian Capital Advisors, is through the week ended Oct. 26.

Among the top highlights: Cannabis firms have raised more than $2.2 billion since the beginning of October as investors shift their focus from Canada and ramp up activity in the U.S.  Through Oct. 26, more than $8.2 billion has been invested in the industry this year.

Effect of Cannabidiol on Drop Seizures in the Lennox–Gastaut Syndrome

BACKGROUND

Cannabidiol has been used for treatment-resistant seizures in patients with severe early-onset epilepsy. We investigated the efficacy and safety of cannabidiol added to a regimen of conventional antiepileptic medication to treat drop seizures in patients with the Lennox–Gastaut syndrome, a severe developmental epileptic encephalopathy.